Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$6,807,411
-$350,769 QoQ
Shares Held
26,804
-8.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.39%
of 13F equity value
Holder Rank
#1,368
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUE Private Wealth Advisors holds $27,309,850 across 8 Drug Manufacturers - General names. JNJ ranks #2 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,739 | $8,082,959 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
26,804 | $6,807,411 | |
| 3 | ABBV |
AbbVie Inc.
|
24,787 | $6,237,400 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,029 | $3,473,226 | |
| 5 | PFE |
Pfizer Inc
|
66,968 | $1,612,589 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,727 | $560,469 | |
| 7 | AMGN |
Amgen Inc
|
808 | $292,592 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,925 | $243,204 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,807,411 | 26,804 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $7,158,180 | 29,284 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,638,335 | 32,077 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,991,661 | 32,314 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,757,246 | 31,144 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,937,388 | 29,772 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,422,190 | 30,578 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,067,940 | 31,272 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,733,976 | 32,389 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $4,835,077 | 30,565 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,512,855 | 16,032 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $2,672,358 | 17,158 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,014,284 | 18,211 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,827,510 | 18,242 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,219,092 | 18,223 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,924,307 | 17,901 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,179,204 | 17,910 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $3,188,899 | 17,993 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $3,099,104 | 18,116 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,861,780 | 17,720 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,768,620 | 16,806 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,797,730 | 17,023 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,415,310 | 15,347 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $2,288,136 | 15,369 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $2,081,745 | 14,803 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $1,938,494 | 14,783 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||